Funded by France 2030 (ANR-24-MIEM-0004), OBEPINE+ is part of the french national plan for prevention against emerging infectious diseases and high-risk pathogens (pandemic preparedness). OBEPINE+ aims to build a national R&D platform in France for epidemiology via wastewater (#WBE). The objective is to analyse wastewater for early detection and monitoring of epidemics. The consortium brings together 18 partners (companies and academics) and experts in medical virology, molecular biology, genomics, microbiology, hydrology and mathematics.
OBEPINE was the first to demonstrate in 2020 that quantifying SARS-CoV-2 in wastewater enables to track the dynamics of the epidemic. This work is now being used by OBEPINE teams to extend the WBE approach to other infectious diseases.
Website: https://obepine-plus.sorbonne-universite.fr/en
Company Details
- Address
- Paris, Fr
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Keywords
- Wastewater-Based Epidemiology #WBE - Détection des maladies infectieuses via les eaux usées.
- HQ
- Paris
Obepine Questions
Obepine's website is https://obepine-plus.sorbonne-universite.fr/en
Obepine's LinkedIn profile is https://fr.linkedin.com/company/obepinegis
Obepine's industry is
Research Services
Obepine's categories are Research Services
